Mail-Order Pharmacies Deliver Peace of Mind During COVID

OSRX ships post-op drops directly to your practice or patients at no added cost, allowing at-risk patients to avoid unnecessary visits to the pharmacy before and after surgery.

By Damien Goldberg, MD, Wolstan & Goldberg Eye Associates

COVID-19 has changed our world – personally and professionally. That much is undeniable. 

At home, our “new normal” means finding creative ways to educate, socialize and entertain our children – while simultaneously keeping them out of harm’s way. We use technology to our advantage to remain socially connected to our extended family and friends as well as participate in religious services and rituals. It’s far from perfect, but we’re making it work.

Professionally, things are a bit more complicated. Across the country, ophthalmologists, myself included, are grappling with the dilemma of how to reopen their practices safely and responsibly. Considering the a typical cataract patient is 72 years old, implementing appropriate safeguards is a seemingly daunting – but far from impossible – task.

According to the CDC and AAO, simple changes that can be implemented relatively easily include screening patients prior to entry for COVID symptoms (fever, cough, body aches, etc.), installing plexiglass barriers in reception areas, reducing overall patient volume, requiring patients to wear masks and instructing staff to be in full PPE at all times. 

But you can take patient safety even a step further.

At my practice, we’re achieving an added layer of protection by prescribing “OMNI” post-op drops from OSRX – a PCAB-accredited 503A compounding pharmacy that ships compounded preparations directly to your patient’s home or your practice at no added cost. Think of it as giving your patients the option of free curbside pickup or in-home delivery for their meds. Importantly, this allows them to avoid crowded pharmacy lines and maintain a higher level of social distance prior to surgery – precautions that cannot be overestimated at a time like this.

What’s more, OSRX will be soon providing surgeons with the option to prescribe a dilation drop (cyclopentolate 1% / phenylephrine 2.5%) and have it sent directly to their patients – allowing them to self-dilate prior to arriving for surgery. The goal of this innovative approach, already being implemented by the likes of James Loden, MD, of Loden Vision and Elizabeth Yeu, MD, at Virginia Eye Consultants, is to limit the number of patients sitting in waiting rooms, adhere to social distancing guidelines and realize greater operational efficiencies and outputs. 

In addition to these COVID-related benefits, it’s important to note that I also observe a higher level of patient compliance when using OMNI drops – thanks to the brilliant simplicity of combining multiple agents like Prednisolone Phosphate 1%, Gatifloxacin 0.5% and Bromfenac 0.075% into a single dose. This reduces the number of drops needed post-operatively, streamlines treatment and saves our patients money.

Finally, OSRX recently debuted a fully secure, HIPAA-compliant prescriber portal that allows you to seamlessly submit, manage and track all prescriptions online. The OSRX Prescriber Portal also has the capability to sync with EMR systems, allowing for the auto-population of patient information and less data entry. 

For more information on OSRX, visit

Professional Disclosure: Dr. Goldberg is the Chief Medical Officer at Ocular Science® (an OSRX affiliate) and has a financial interest in the company.

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded medications are generally not reviewed by the FDA for safety or efficacy. OSRX does not compound copies of commercially available products. References available upon request.

Click here to view potential contraindications.